Human Molecular Genetics Advance Access originally published online on October 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2003, Vol. 12, No. 24 3385-3395
DOI: 10.1093/hmg/ddg363
© 2003 Oxford University Press
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease
1Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases ‘Aldo e Cele Daccò’, Villa Camozzi, Ranica, Italy and 2Unit of Nephrology and Dialysis, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Italy
Received September 4, 2003; Accepted October 17, 2003
Mutations in complement factor H (HF1) gene have been reported in non-Shiga toxin-associated and diarrhoea-negative haemolytic uraemic syndrome (D-HUS). We analysed the complete HF1 in 101 patients with HUS, in 32 with thrombotic thrombocytopenic purpura (TTP) and in 106 controls to evaluate the frequency of HF1 mutations, the clinical outcome in mutation and non-mutation carriers and the role of HF1 polymorphisms in the predisposition to HUS. We found 17 HF1 mutations (16 heterozygous, one homozygous) in 33 HUS patients. Thirteen mutations were located in exons XXII and XXIII. No TTP patient carried HF1 mutations. The disease manifested earlier and the mortality rate was higher in mutation carriers than in non-carriers. Kidney transplants invariably failed for disease recurrences in patients with HF1 mutations, while in non-mutated patients half of the grafts were functioning after 1 year. Three HF1 polymorphic variants were strongly associated with D-HUS: -257T (promoter region), 2089G (exonXIV, silent) and 2881T (963Asp, SCR16). The association was stronger in patients without HF1 mutations. Two or three disease-associated variants led to a higher risk of HUS than a single one. Analysis of available relatives of mutated patients revealed a penetrance of 50%. In 5/9 families the proband inherited the mutation from one parent and two disease-associated variants from the other, while unaffected carriers inherited the protective variants. In conclusion HF1 mutations are frequent in patients with D-HUS (24%). Common polymorphisms of HF1 may contribute to D-HUS manifestation in subjects with and without HF1 mutations.
* To whom correspondence should be addressed at: Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases ‘Aldo e Cele Daccò’, Villa Camozzi, Via Camozzi 3, 24020 Ranica, Italy. Tel: +39 03545351; Fax: +39 0354535377; Email: noris{at}marionegri.it
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Noris and G. Remuzzi Atypical Hemolytic-Uremic Syndrome N. Engl. J. Med., October 22, 2009; 361(17): 1676 - 1687. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tortajada, T. Montes, R. Martinez-Barricarte, B. P. Morgan, C. L. Harris, and S. R. de Cordoba The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity Hum. Mol. Genet., September 15, 2009; 18(18): 3452 - 3461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Strobel, P. F. Hoyer, C. J. Mache, E. Sulyok, W.-s. Liu, H. Richter, M. Oppermann, P. F. Zipfel, and M. Jozsi Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome Nephrol. Dial. Transplant., August 7, 2009; (2009) gfp388v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lhotta, A. R. Janecke, J. Scheiring, B. Petzlberger, T. Giner, V. Fally, R. Wurzner, L. B. Zimmerhackl, G. Mayer, and V. Fremeaux-Bacchi A Large Family with a Gain-of-Function Mutation of Complement C3 Predisposing to Atypical Hemolytic Uremic Syndrome, Microhematuria, Hypertension and Chronic Renal Failure Clin. J. Am. Soc. Nephrol., August 1, 2009; 4(8): 1356 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P. Ferreira, A. P. Herbert, C. Cortes, K. A. McKee, B. S. Blaum, S. T. Esswein, D. Uhrin, P. N. Barlow, M. K. Pangburn, and D. Kavanagh The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome J. Immunol., June 1, 2009; 182(11): 7009 - 7018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Saland, P. Ruggenenti, G. Remuzzi, and and the Consensus Study Group Liver-Kidney Transplantation to Cure Atypical Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., May 1, 2009; 20(5): 940 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Klein, M. D. Knudtson, K. E. Lee, and B. E. K. Klein Serum Cystatin C Level, Kidney Disease Markers, and Incidence of Age-Related Macular Degeneration: The Beaver Dam Eye Study Arch Ophthalmol, February 1, 2009; 127(2): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Saland, B. L. Shneider, J. S. Bromberg, P. A. Shi, S. C. Ward, M. S. Magid, C. Benchimol, M. G. Seikaly, S. H. Emre, E. Bresin, et al. Successful Split Liver-Kidney Transplant for Factor H Associated Hemolytic Uremic Syndrome Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 201 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Ferrara, J. E. Merriam, K. B. Freund, R. F. Spaide, B. S. Takahashi, I. Zhitomirsky, H. F. Fine, L. A. Yannuzzi, and R. Allikmets Analysis of Major Alleles Associated With Age-Related Macular Degeneration in Patients With Multifocal Choroiditis: Strong Association With Complement Factor H Arch Ophthalmol, November 1, 2008; 126(11): 1562 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-l. Stahl, F. Vaziri-Sani, S. Heinen, A.-C. Kristoffersson, K.-H. Gydell, R. Raafat, A. Gutierrez, O. Beringer, P. F. Zipfel, and D. Karpman Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation Blood, June 1, 2008; 111(11): 5307 - 5315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Blom, F. Bergstrom, M. Edey, M. Diaz-Torres, D. Kavanagh, A. Lampe, J. A. Goodship, L. Strain, N. Moghal, M. McHugh, et al. A Novel Non-Synonymous Polymorphism (p.Arg240His) in C4b-Binding Protein Is Associated with Atypical Hemolytic Uremic Syndrome and Leads to Impaired Alternative Pathway Cofactor Activity J. Immunol., May 1, 2008; 180(9): 6385 - 6391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Martinez-Barricarte, G. Pianetti, R. Gautard, J. Misselwitz, L. Strain, V. Fremeaux-Bacchi, C. Skerka, P. F. Zipfel, T. Goodship, M. Noris, et al. The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., March 1, 2008; 19(3): 639 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jozsi, C. Licht, S. Strobel, S. L. H. Zipfel, H. Richter, S. Heinen, P. F. Zipfel, and C. Skerka Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency Blood, February 1, 2008; 111(3): 1512 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Fang, V. Fremeaux-Bacchi, M. K. Liszewski, G. Pianetti, M. Noris, T. H. J. Goodship, and J. P. Atkinson Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome Blood, January 15, 2008; 111(2): 624 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Thompson, B. E.K. Klein, R. Klein, Z. Xu, J. Capriotti, T. Joshi, D. Leontiev, K. E. Lee, R. C. Elston, and S. K. Iyengar Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes Hum. Mol. Genet., September 1, 2007; 16(17): 2135 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. Sellier-Leclerc, V. Fremeaux-Bacchi, M.-A. Dragon-Durey, M.-A. Macher, P. Niaudet, G. Guest, B. Boudailliez, F. Bouissou, G. Deschenes, S. Gie, et al. Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2392 - 2400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mizuno, M. Nozaki, N. Morine, N. Suzuki, K. Nishikawa, B. P. Morgan, and S. Matsuo A Protein Toxin from the Sea Anemone Phyllodiscus semoni Targets the Kidney and Causes a Severe Renal Injury with Predominant Glomerular Endothelial Damage Am. J. Pathol., August 1, 2007; 171(2): 402 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Pickering, E. G. de Jorge, R. Martinez-Barricarte, S. Recalde, A. Garcia-Layana, K. L. Rose, J. Moss, M. J. Walport, H. T. Cook, S. R. de Cordoba, et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains J. Exp. Med., June 11, 2007; 204(6): 1249 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kavanagh, A. Richards, V. Fremeaux-Bacchi, M. Noris, T. Goodship, G. Remuzzi, and J. P. Atkinson Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 591 - 596. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Pulido, J. P. McConnell, L. M. Peterson, W. E. Highsmith, R. J. Lennon, S. C. Bryant, P. B. Berger, and V. Somers Relationship Between Age-Related Macular Degeneration-Associated Variants of Complement Factor H and LOC387715 With Coronary Artery Disease Mayo Clin. Proc., March 1, 2007; 82(3): 301 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Heinen, M. Jozsi, A. Hartmann, M. Noris, G. Remuzzi, C. Skerka, and P. F. Zipfel Hemolytic Uremic Syndrome: A Factor H Mutation (E1172Stop) Causes Defective Complement Control at the Surface of Endothelial Cells J. Am. Soc. Nephrol., February 1, 2007; 18(2): 506 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. de Jorge, C. L. Harris, J. Esparza-Gordillo, L. Carreras, E. A. Arranz, C. A. Garrido, M. Lopez-Trascasa, P. Sanchez-Corral, B. P. Morgan, and S. R. de Cordoba Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome PNAS, January 2, 2007; 104(1): 240 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kavanagh, T. H. J. Goodship, and A. Richards Atypical haemolytic uraemic syndrome Br. Med. Bull., October 5, 2006; (2006) ldl004v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Caprioli, M. Noris, S. Brioschi, G. Pianetti, F. Castelletti, P. Bettinaglio, C. Mele, E. Bresin, L. Cassis, S. Gamba, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood, August 15, 2006; 108(4): 1267 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fremeaux-Bacchi, E. A. Moulton, D. Kavanagh, M.-A. Dragon-Durey, J. Blouin, A. Caudy, N. Arzouk, R. Cleper, M. Francois, G. Guest, et al. Genetic and Functional Analyses of Membrane Cofactor Protein (CD46) Mutations in Atypical Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2017 - 2025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Thurman and V. M. Holers The Central Role of the Alternative Complement Pathway in Human Disease J. Immunol., February 1, 2006; 176(3): 1305 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bresin, E. Daina, M. Noris, F. Castelletti, R. Stefanov, P. Hill, T. H.J. Goodship, G. Remuzzi, and for the International Registry of Recurrent and Fa Outcome of Renal Transplantation in Patients with Non-Shiga Toxin-Associated Hemolytic Uremic Syndrome: Prognostic Significance of Genetic Background Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 88 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jozsi, S. Heinen, A. Hartmann, C. W. Ostrowicz, S. Halbich, H. Richter, A. Kunert, C. Licht, R. E. Saunders, S. J. Perkins, et al. Factor H and Atypical Hemolytic Uremic Syndrome: Mutations in the C-Terminus Cause Structural Changes and Defective Recognition Functions J. Am. Soc. Nephrol., January 1, 2006; 17(1): 170 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Fremeaux-Bacchi, E J Kemp, J A Goodship, M-A Dragon-Durey, L Strain, C Loirat, H-W Deng, and T H J Goodship The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts J. Med. Genet., November 1, 2005; 42(11): 852 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kavanagh, E. J. Kemp, E. Mayland, R. J. Winney, J. S. Duffield, G. Warwick, A. Richards, R. Ward, J. A Goodship, and T. H.J. Goodship Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2150 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Hageman, D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, et al. From The Cover: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration PNAS, May 17, 2005; 102(20): 7227 - 7232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noris, S. Bucchioni, M. Galbusera, R. Donadelli, E. Bresin, F. Castelletti, J. Caprioli, S. Brioschi, F. Scheiflinger, G. Remuzzi, et al. Complement Factor H Mutation in Familial Thrombotic Thrombocytopenic Purpura with ADAMTS13 Deficiency and Renal Involvement J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1177 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noris and G. Remuzzi Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1035 - 1050. [Full Text] [PDF]
|
|
|
|
|
|
J. Esparza-Gordillo, E. G. d. Jorge, A. Buil, L. C. Berges, M. Lopez-Trascasa, P. Sanchez-Corral, and S. R. d. Cordoba Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 Hum. Mol. Genet., March 1, 2005; 14(5): 703 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Fremeaux-Bacchi, M-A Dragon-Durey, J Blouin, C Vigneau, D Kuypers, B Boudailliez, C Loirat, E Rondeau, and W H Fridman Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome J. Med. Genet., June 1, 2004; 41(6): e84 - e84. [Full Text] [PDF]
|
|